Cephalostatin 1 inactivates Bcl-2 by hyperphosphorylation independent of M-phase arrest and DNA damage

Irina M Müller1, Verena M Dirsch, Anita Rudy

  • 1Department of Pharmacy, Center of Drug Research, University of Munich, Germany.

Molecular Pharmacology
|February 11, 2005
PubMed

Insights

Marine product cephalostatin 1 triggers apoptosis in leukemia cells by activating c-Jun NH2-terminal kinase (JNK), leading to Bcl-2 protein inactivation. This occurs independently of DNA damage or M-phase arrest, revealing a novel cell death mechanism.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Pharmacology

Background:

  • Cephalostatin 1, a marine compound, induces apoptosis in Jurkat leukemia T cells via a unique pathway.
  • The antiapoptotic protein Bcl-2 plays a role in cellular resistance to apoptosis.

Purpose of the Study:

  • To elucidate the mechanism by which cephalostatin 1 induces apoptosis, focusing on the role of Bcl-2.
  • To identify the specific signaling pathway and kinase involved in cephalostatin 1-induced Bcl-2 inactivation.

Main Methods:

  • Overexpression of Bcl-2 and mutated Bcl-2 in Jurkat cells.
  • Treatment with cephalostatin 1 and a c-Jun NH2-terminal kinase (JNK) inhibitor (SP600125).
  • Analysis of Bcl-2 phosphorylation, JNK activation, DNA damage (comet assay), and cell cycle progression (flow cytometry).

Main Results:

  • Overexpression of Bcl-2 only partially protected cells against cephalostatin 1-induced apoptosis.
  • Cephalostatin 1 induced hyperphosphorylation of Bcl-2 at Thr69 and Ser87, inactivating its function.
  • Mutations preventing phosphorylation at Thr69 and Ser87 conferred complete protection.
  • Cephalostatin 1 activated JNK, and JNK inhibition reduced Bcl-2 phosphorylation.
  • Cephalostatin 1 did not induce DNA damage or M-phase arrest.

Conclusions:

  • Cephalostatin 1 induces JNK activation, leading to Bcl-2 hyperphosphorylation and inactivation, thereby promoting apoptosis.
  • This mechanism is independent of DNA damage and M-phase arrest, suggesting a novel pathway for apoptosis induction by marine natural products.

Related Concept Videos

DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Separation of Sister Chromatids02:17

Separation of Sister Chromatids

At the transition from prophase to metaphase, there is a reduction in cohesion along the chromosomal arms, resulting in the resolution of sister chromatids. However, residual cohesin connections remain to hold the sister chromatids together until the transition from metaphase to anaphase. The residual connection prevents any premature separation of sister chromatids, blocking the risks of aneuploidy within the daughter cells.
At the onset of anaphase, separase, a proteolytic enzyme, is...